It is important to emphasize that the development of cardiovascular diseases can be initiated by mutations associated with blood cancer (DNMT3A, JAK2, ASXL1, and TET2) [18, 21, 64]. This evidence concerns the gene TET2 and hematopoietic and lymphoid system neoplasm.